Global Oral Mesalazine market size is predicted to grow from US$ 94.2 million in 2025 to US$ 118 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031. Get Access Now!

Global Oral Mesalazine Market Growth Status and Outlook 2025-2031

The global Oral Mesalazine market size is predicted to grow from US$ 94.2 million in 2025 to US$ 118 million in 2031; it is expected to grow at a CAGR of 3.8% from 2025 to 2031. Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohns disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. LPI (LP Information) newest research report, the Oral Mesalazine Industry Forecast looks at past sales and reviews total world Oral Mesalazine sales in 2024, providing a comprehensive analysis by region and market sector of projected Oral Mesalazine sales for 2025 through 2031. With Oral Mesalazine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oral Mesalazine industry. This Insight Report provides a comprehensive analysis of the global Oral Mesalazine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oral Mesalazine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Oral Mesalazine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oral Mesalazine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oral Mesalazine. This report presents a comprehensive overview, market shares, and growth opportunities of Oral Mesalazine market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Tablets &nbsp;&nbsp;&nbsp; Capsules &nbsp;&nbsp;&nbsp; Granule Segmentation by Application: &nbsp;&nbsp;&nbsp; Ulcerative Colitis &nbsp;&nbsp;&nbsp; Crohns Disease &nbsp;&nbsp;&nbsp; Inflammatory Bowel Disease &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; AbbVie &nbsp;&nbsp;&nbsp; Shire &nbsp;&nbsp;&nbsp; Salix Pharmaceuticals &nbsp;&nbsp;&nbsp; Ferring Global &nbsp;&nbsp;&nbsp; Teva Pharmaceutical Industries &nbsp;&nbsp;&nbsp; Morningside Healthcare &nbsp;&nbsp;&nbsp; Dr. Falk Pharma UK &nbsp;&nbsp;&nbsp; Nogra Pharma Limited &nbsp;&nbsp;&nbsp; Tillotts Pharma

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Oral Mesalazine Market Size (2020-2031) &nbsp;2.1.2 Oral Mesalazine Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for Oral Mesalazine by Country/Region (2020, 2024 & 2031) &nbsp;2.2 Oral Mesalazine Segment by Type &nbsp;2.2.1 Tablets &nbsp;2.2.2 Capsules &nbsp;2.2.3 Granule &nbsp;2.3 Oral Mesalazine Market Size by Type &nbsp;2.3.1 Oral Mesalazine Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global Oral Mesalazine Market Size Market Share by Type (2020-2025) &nbsp;2.4 Oral Mesalazine Segment by Application &nbsp;2.4.1 Ulcerative Colitis &nbsp;2.4.2 Crohn's Disease &nbsp;2.4.3 Inflammatory Bowel Disease &nbsp;2.4.4 Others &nbsp;2.5 Oral Mesalazine Market Size by Application &nbsp;2.5.1 Oral Mesalazine Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global Oral Mesalazine Market Size Market Share by Application (2020-2025) 3 Oral Mesalazine Market Size by Player &nbsp;3.1 Oral Mesalazine Market Size Market Share by Player &nbsp;3.1.1 Global Oral Mesalazine Revenue by Player (2020-2025) &nbsp;3.1.2 Global Oral Mesalazine Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global Oral Mesalazine Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 Oral Mesalazine by Region &nbsp;4.1 Oral Mesalazine Market Size by Region (2020-2025) &nbsp;4.2 Global Oral Mesalazine Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Oral Mesalazine Market Size Growth (2020-2025) &nbsp;4.4 APAC Oral Mesalazine Market Size Growth (2020-2025) &nbsp;4.5 Europe Oral Mesalazine Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa Oral Mesalazine Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas Oral Mesalazine Market Size by Country (2020-2025) &nbsp;5.2 Americas Oral Mesalazine Market Size by Type (2020-2025) &nbsp;5.3 Americas Oral Mesalazine Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Oral Mesalazine Market Size by Region (2020-2025) &nbsp;6.2 APAC Oral Mesalazine Market Size by Type (2020-2025) &nbsp;6.3 APAC Oral Mesalazine Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe Oral Mesalazine Market Size by Country (2020-2025) &nbsp;7.2 Europe Oral Mesalazine Market Size by Type (2020-2025) &nbsp;7.3 Europe Oral Mesalazine Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Oral Mesalazine by Region (2020-2025) &nbsp;8.2 Middle East & Africa Oral Mesalazine Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa Oral Mesalazine Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global Oral Mesalazine Market Forecast &nbsp;10.1 Global Oral Mesalazine Forecast by Region (2026-2031) &nbsp;10.1.1 Global Oral Mesalazine Forecast by Region (2026-2031) &nbsp;10.1.2 Americas Oral Mesalazine Forecast &nbsp;10.1.3 APAC Oral Mesalazine Forecast &nbsp;10.1.4 Europe Oral Mesalazine Forecast &nbsp;10.1.5 Middle East & Africa Oral Mesalazine Forecast &nbsp;10.2 Americas Oral Mesalazine Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market Oral Mesalazine Forecast &nbsp;10.2.2 Canada Market Oral Mesalazine Forecast &nbsp;10.2.3 Mexico Market Oral Mesalazine Forecast &nbsp;10.2.4 Brazil Market Oral Mesalazine Forecast &nbsp;10.3 APAC Oral Mesalazine Forecast by Region (2026-2031) &nbsp;10.3.1 China Oral Mesalazine Market Forecast &nbsp;10.3.2 Japan Market Oral Mesalazine Forecast &nbsp;10.3.3 Korea Market Oral Mesalazine Forecast &nbsp;10.3.4 Southeast Asia Market Oral Mesalazine Forecast &nbsp;10.3.5 India Market Oral Mesalazine Forecast &nbsp;10.3.6 Australia Market Oral Mesalazine Forecast &nbsp;10.4 Europe Oral Mesalazine Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market Oral Mesalazine Forecast &nbsp;10.4.2 France Market Oral Mesalazine Forecast &nbsp;10.4.3 UK Market Oral Mesalazine Forecast &nbsp;10.4.4 Italy Market Oral Mesalazine Forecast &nbsp;10.4.5 Russia Market Oral Mesalazine Forecast &nbsp;10.5 Middle East & Africa Oral Mesalazine Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market Oral Mesalazine Forecast &nbsp;10.5.2 South Africa Market Oral Mesalazine Forecast &nbsp;10.5.3 Israel Market Oral Mesalazine Forecast &nbsp;10.5.4 Turkey Market Oral Mesalazine Forecast &nbsp;10.6 Global Oral Mesalazine Forecast by Type (2026-2031) &nbsp;10.7 Global Oral Mesalazine Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market Oral Mesalazine Forecast 11 Key Players Analysis &nbsp;11.1 AbbVie &nbsp;11.1.1 AbbVie Company Information &nbsp;11.1.2 AbbVie Oral Mesalazine Product Offered &nbsp;11.1.3 AbbVie Oral Mesalazine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 AbbVie Main Business Overview &nbsp;11.1.5 AbbVie Latest Developments &nbsp;11.2 Shire &nbsp;11.2.1 Shire Company Information &nbsp;11.2.2 Shire Oral Mesalazine Product Offered &nbsp;11.2.3 Shire Oral Mesalazine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Shire Main Business Overview &nbsp;11.2.5 Shire Latest Developments &nbsp;11.3 Salix Pharmaceuticals &nbsp;11.3.1 Salix Pharmaceuticals Company Information &nbsp;11.3.2 Salix Pharmaceuticals Oral Mesalazine Product Offered &nbsp;11.3.3 Salix Pharmaceuticals Oral Mesalazine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 Salix Pharmaceuticals Main Business Overview &nbsp;11.3.5 Salix Pharmaceuticals Latest Developments &nbsp;11.4 Ferring Global &nbsp;11.4.1 Ferring Global Company Information &nbsp;11.4.2 Ferring Global Oral Mesalazine Product Offered &nbsp;11.4.3 Ferring Global Oral Mesalazine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Ferring Global Main Business Overview &nbsp;11.4.5 Ferring Global Latest Developments &nbsp;11.5 Teva Pharmaceutical Industries &nbsp;11.5.1 Teva Pharmaceutical Industries Company Information &nbsp;11.5.2 Teva Pharmaceutical Industries Oral Mesalazine Product Offered &nbsp;11.5.3 Teva Pharmaceutical Industries Oral Mesalazine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 Teva Pharmaceutical Industries Main Business Overview &nbsp;11.5.5 Teva Pharmaceutical Industries Latest Developments &nbsp;11.6 Morningside Healthcare &nbsp;11.6.1 Morningside Healthcare Company Information &nbsp;11.6.2 Morningside Healthcare Oral Mesalazine Product Offered &nbsp;11.6.3 Morningside Healthcare Oral Mesalazine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Morningside Healthcare Main Business Overview &nbsp;11.6.5 Morningside Healthcare Latest Developments &nbsp;11.7 Dr. Falk Pharma UK &nbsp;11.7.1 Dr. Falk Pharma UK Company Information &nbsp;11.7.2 Dr. Falk Pharma UK Oral Mesalazine Product Offered &nbsp;11.7.3 Dr. Falk Pharma UK Oral Mesalazine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 Dr. Falk Pharma UK Main Business Overview &nbsp;11.7.5 Dr. Falk Pharma UK Latest Developments &nbsp;11.8 Nogra Pharma Limited &nbsp;11.8.1 Nogra Pharma Limited Company Information &nbsp;11.8.2 Nogra Pharma Limited Oral Mesalazine Product Offered &nbsp;11.8.3 Nogra Pharma Limited Oral Mesalazine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.8.4 Nogra Pharma Limited Main Business Overview &nbsp;11.8.5 Nogra Pharma Limited Latest Developments &nbsp;11.9 Tillotts Pharma &nbsp;11.9.1 Tillotts Pharma Company Information &nbsp;11.9.2 Tillotts Pharma Oral Mesalazine Product Offered &nbsp;11.9.3 Tillotts Pharma Oral Mesalazine Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.9.4 Tillotts Pharma Main Business Overview &nbsp;11.9.5 Tillotts Pharma Latest Developments 12 Research Findings and Conclusion

Report	Global Oral Mesalazine Market Growth (Status and Outlook) 2025-2031
Selected License	Multi ID: LPI36072

Buyer Information

Order Summary